Lijie Zhong
About Lijie Zhong
Lijie Zhong serves as the Vice President of Biometrics, Epidemiology, and Real World Evidence at Brii Biosciences and as Senior Vice President and Head of Biometrics at Vera Therapeutics, Inc. He has extensive experience in biostatistics and clinical trials, having previously held an executive role at Gilead Sciences.
Work at Brii Biosciences
Lijie Zhong serves as the Vice President of Biometrics, Epidemiology, and Real World Evidence at Brii Biosciences. He has held this position since 2020, contributing to the organization for four years. In this role, he leads initiatives related to the design, data collection, analysis, and interpretation of clinical trials. His expertise in biometrics and epidemiology plays a crucial role in advancing the company's research and development efforts.
Current Role at Vera Therapeutics
In addition to his role at Brii Biosciences, Lijie Zhong is the Senior Vice President and Head of Biometrics at Vera Therapeutics, Inc. He has been with the company since 2022, working in Brisbane, California. His responsibilities include overseeing biometrics operations and ensuring the effective integration of data analysis within clinical studies.
Experience at Gilead Sciences
Before joining Brii Biosciences, Lijie Zhong worked at Gilead Sciences as the Executive Director of Biostatistics. He held this position for six years, starting in 2018, and was based in Foster City. His experience at Gilead Sciences provided him with a strong foundation in biostatistics and clinical trial management.
Education and Expertise
Lijie Zhong holds a Ph.D. and an MBA, which equip him with a robust academic background in both scientific research and business management. His educational qualifications support his expertise in biometrics, epidemiology, and real-world evidence, enabling him to lead complex clinical studies effectively.